NCAPH-YAP1相互作用促进乳腺癌干和瘤进展
Caixin Qiu1,2, Yansha Wei3, Jiehua Li4,5
1Department of Gastroenterology and Gland Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi Zhuang Autonomous Region, China.
NCAPH通过Hippo-YAP1通路促进癌症干细胞 (CSC) 特性,驱动乳腺癌 (BC) 转移和耐药性. 抑制YAP1可以逆转这些影响,将NCAPH确定为转移性BC的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 乳腺癌 (BC) 仍然是全球女性癌症相关死亡的主要原因.
- 尽管取得了进展,但大约30%的患者由于癌症干细胞 (CSC) 发展转移性BC,这些干细胞导致复发,转移和治疗抵抗.
研究的目的:
- 调查NCAPH在乳腺癌干细胞 (BCSC) 特征中的作用及其与BC预后的关联.
- 阐明NCAPH影响BC进展和转移的分子机制,特别是其与Hippo-YAP1信号通路的相互作用.
主要方法:
- 对BC数据集 (GEO,cBioportal,TCGA) 的生物信息分析,以确定NCAPH作为与BCSC相关的基因.
- 在体外和体内实验中评估NCAPH对BC细胞的功能影响,包括增殖,迁移和入侵.
- 转录基因测序,GSEA,共免疫沉和免疫光,以探索NCAPH与Hippo-YAP1通路和YAP1活动的相互作用.
主要成果:
- 在BC中,NCAPH过度表达,与晚期和不良预后相关.
- NCAPH增强了BCSC的特性,促进了细胞周期的进展,增殖,迁移和入侵.
- NCAPH促进YAP1脱和核转移,增强BCSC特征和恶性瘤,YAP1抑制可以逆转效应.
结论:
- NCAPH是乳腺癌的新型致癌因子,通过与YAP1的相互作用促进恶性瘤和CSC特征.
- 准NCAPH-YAP1轴是克服BC转移和药物耐药性的有希望的治疗策略.
更多相关视频
09:55All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
Published on: December 20, 2021
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
相关概念视频
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Induced Pluripotent Stem Cells
Somatic...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
